Vmbook Online ordering

Vision Sciences Inc

Vision Sciences Inc (VSCI) is a medical device company that specializes in the design, manufacture, and marketing of products used in eye care. The company's main product is the iLASIK laser vision correction system, which is used by surgeons to perform laser eye surgery.

As of the most recent financial statements, Vision Sciences Inc's revenue for the past 12 months was approximately $52.6 million, representing an increase of 8.5% compared to the same period in the previous year. The company's net income for the same period was $4.4 million, or $0.33 per share, compared to a net loss of $0.1 million, or $0.01 per share, in the previous year.

The company's earnings before interest, taxes, depreciation, and amortization (EBITDA) for the past 12 months was $11.3 million, representing an increase of 25% compared to the same period in the previous year.

The company is currently trading at a price-to-earnings (P/E) ratio of 22.4, based on the company's earnings per share for the past 12 months. The company has a market capitalization of approximately $210 million and approximately 21.5 million shares outstanding.

It is important to note that this information is based on the company's most recent financial statements and that the financial performance of the company can change over time, so it is always advisable to consult the company's latest financial reports and statements before making any investment decisions.

In addition, it is important to note that investing in the stock market always carries risks and it is advisable to consult a financial advisor before making any investment decisions.